| P50 | author | Melissa A Lewis | Q70481230 |
| | Stacey W Martin | Q88977516 |
| | Shelley M Zansky | Q106342535 |
| | Amy E Blain | Q114413551 |
| | Tami H Skoff | Q114782798 |
| | Kathy Kudish | Q114782833 |
| P2093 | author name string | James Watt | |
| | Paul R Cieslak | |
| | Nong Shang | |
| | Karen Scherzinger | |
| | Melissa McMahon | |
| P2860 | cites work | Changing pertussis epidemiology: everything old is new again | Q26853637 |
| | Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model | Q34387963 |
| | Protecting newborns from pertussis - the challenge of complete cocooning | Q34468909 |
| | Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q34504734 |
| | Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, suppo | Q34590779 |
| | Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial | Q35097262 |
| | Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States | Q35997485 |
| | Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis | Q36676385 |
| | The influence of maternal immunization on infant immune responses | Q36842113 |
| | The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam | Q37410323 |
| | Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction. | Q37410332 |
| | Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers | Q38426254 |
| | Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis | Q38756466 |
| | Parental Tdap boosters and infant pertussis: a case-control study | Q39128479 |
| | Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis | Q39394033 |
| | Accelerating control of pertussis in England and Wales | Q39662144 |
| | Risk Factors for Pertussis Among Hispanic Infants: Metropolitan Portland, Oregon, 2010-2012. | Q40109201 |
| | An Assessment of the Cocooning Strategy for Preventing Infant Pertussis-United States, 2011. | Q40454304 |
| | Sources of Infant Pertussis Infection in the United States | Q40564598 |
| | The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia | Q40593399 |
| | Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy | Q40648284 |
| | The optimal gestation for pertussis vaccination during pregnancy: a prospective cohort study | Q40758738 |
| | Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy | Q40925256 |
| | Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator | Q40997472 |
| | A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. | Q41694017 |
| | Effectiveness of maternal pertussis vaccination in England: an observational study. | Q42205386 |
| | Transmission of Bordetella pertussis to young infants | Q43464211 |
| | Immune responses in infants whose mothers received Tdap vaccine during pregnancy. | Q43898020 |
| | Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants | Q44078770 |
| | Priming with whole-cell versus acellular pertussis vaccine | Q45080287 |
| | Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. | Q45909451 |
| | Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection | Q46325996 |
| | Pertussis--United States, 2001-2003. | Q47232749 |
| | Pertussis--United States, 1997-2000. | Q47585109 |
| | Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection | Q57392965 |
| | Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Im | Q82102229 |
| | Optimal Timing of Immunization Against Pertussis During Pregnancy | Q89249934 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | maternal health | Q6786626 |
| P304 | page(s) | 1977-1983 | |
| P577 | publication date | 2017-09-28 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation | |
| P478 | volume | 65 | |